Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$657,274
+$108,018 QoQ
Shares Held
2,588
+15.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#3,434
of 4,676 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Darden Wealth Group Inc holds $5,302,155 across 5 Drug Manufacturers - General names. JNJ ranks #3 (12.4% of the industry book) .
All Filings in JNJ
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $657,274 | 2,588 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $549,256 | 2,247 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $485,711 | 2,347 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $435,180 | 2,347 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $352,241 | 2,306 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $481,267 | 2,902 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $424,748 | 2,937 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $491,203 | 3,031 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $449,588 | 3,076 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $625,483 | 3,954 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $730,878 | 4,663 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||